section name header

Information

Population: Adults without known dyslipidemia.

Organizations

ImagesUSPSTF 2016, AHA/ACC 2018, Canadian Cardiovascular Society (CCS) 2021, AACE 2017, VA/DoD 2020

Screening Recommendations

–Screen all adults within recommended age range.

Images

Images

–Use lipid data to determine risk score (ie, ASCVD risk calculator: https://tools.acc.org/ascvd-risk-estimator-plus) to determine need for primary prevention.

–Use lipid data, other levels (FPG/HgbA1c, eGFR), with Framingham Risk Score (FRS) or the Cardiovascular Life Expectancy Model (CLEM) to determine need for primary prevention. (CCS)

–Consider screening adults regardless of age with other risk factors (clinical evidence of atherosclerosis, abdominal aortic aneurysm, diabetes mellitus, arterial hypertension , cigarette smoking, stigmata of dyslipidemia-corneal arcus, xanthelasma, xanthoma), family history of premature CVD or dyslipidemia, CKD (eGFR 60 mL/min/1.73 m2), BMI 30, inflammatory diseases (RA, SLE, PsA, AS, IBD), HIV infection, erectile dysfunction, COPD, history of hypertensive disorder of pregnancy. (CCS)

Sources

VA/DoD Clinical Practice Guideline for the Management of Dyslipidemia for Cardiovascular Risk Reduction. June 2020.

JAMA. 2016;316(19):1997-2007.

Circulation. 2019;139:e1046-e1081.

Can J Cardiol. 2021 Aug;37(8):1129-1150.

Endocr Pract. 2017 Apr;23(Suppl 2).